Prognostic significance of Ep-CAM and Her-2/neu overexpression in invasive breast cancer

International Journal of Cancer

Volumn 98, Issue 6, 2002, Pages 883-888

  Spizzo, Gilbert ^a   Obrist, Peter ^b   Ensinger, Christian ^b   Theurl, Igor ^b   Dünser, Martina ^b   Ramoni, Angela ^b   Gunsilius, Eberhard ^a   Eibl, Günther ^b   Mikuz, Gregor ^b   Gastl, Günther ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Breast; Cancer; Ep CAM; Her 2 neu

Indexed keywords

CELL ADHESION MOLECULE; EPITHELIAL CELL ADHESION MOLECULE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL ADHESION MOLECULES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0037140119     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10270     Document Type: Article

References (38)

1. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
2. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733
3. Ep-CAM: A human epithelial antigen is a homophilic cell-cell adhesion molecule
4. Targets of extinction: Identification of genes whose expression is repressed as a consequence of somatic fusion between cells representing basal and luminal mammary epithelial phenotypes
5. Ep-CAM overexpression in breast cancer as a predictor of survival
6. Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer
7. The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen
8. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
9. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification
10. Evaluation of HER-2/neu (erbB-2) status in breast cancer: From bench to bedside
11. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors
12. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer
13. The neu-oncogene protein as a predictive factor for hematogenous metastases in breast cancer patients
14. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
15. Prognostic significance of HER-2 oncoprotein expression in breast cancer: A 30-year follow-up
16. HER-2/neu amplification predicts poor survival in node-positive breast cancer
17. Long-term survival in breast cancer related to overexpression of the c- erbB-2 oncoprotein: An immunohistochemical study using monoclonal antibody NCL-CB11
18. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer
19. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer
20. Her-2/neu expression in node-negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease
21. c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
22. erbB-2, p53 and efficacy of adjuvant therapy in lymph node-positive breast cancer
23. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
24. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
25. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
26. Her-2/neu analysis in archival tissue samples of human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization
27. The biology of the 17-1A antigen (Ep-CAM)
28. Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue
29. Markers for assessment of nodal metastasis in laryngeal carcinoma
30. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins
31. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
32. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation
33. Expression of Ep-CAM in normal, regenerating, metaplastic and neoplastic liver
34. c-erbB-2 gene product associates with catenins in human cancer cells
35. The structural analysis of adhesions mediated by Ep-CAM
36. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
37. Prognostic significance of HER-2/neu oncoprotein expression in node- positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy
38. Molecular portraits of human breast tumors